Gyrodyne Q3 2026 10-Q: $10.75 a Share and a $21.3M State Offer
Some links pay us a referral fee; each one says so. Disclosure
Filing alert · free
An email when Gyrodyne files with the SEC
An email the day Gyrodyne files something new, with the link to the document on the SEC site.
Quick answer
Gyrodyne, LLC (Nasdaq: GYRO, SEC CIK 1589061), a company in liquidation since 2015, filed its 10-Q for the quarter ended September 30, 2026 on November 13, 2026 (accession 0001437749-26-036653). Net assets in liquidation were $23,640,139, or $10.75 a share on 2,199,308 shares, at September 30, 2026, against $27,055,247 or $12.30 at June 30, 2026 and $25,858,997 or $11.76 at December 31, 2025. The 10-Q says the company received a non-binding offer of $21.3 million from the New York State Department of Environmental Conservation for the undeveloped Flowerfield acres, cut its real estate value by $7,440,000 to match, and reached an agreement in principle (also non-binding) to end its contract with B2K Smithtown LLC, which was priced at $24,000,000 to $28,740,000. No definitive agreement with the State is signed, no property has been sold and no distribution date is set. The share price is not in the filing, so this page does not compare it with the $10.75.
Key takeaways
- Net assets in liquidation fell $3,415,108 in the quarter, from $27,055,247 (June 30, 2026) to $23,640,139 (September 30, 2026), or $1.55 a share (our arithmetic). The company's own bridge shows real estate value down $7.44 million, partly offset by $4.02 million for the B2K closing credit that is no longer counted (10-Q 0001437749-26-036653).
- The $21.3 million is an offer, not a contract. The 10-Q says it is “not binding” and that there is “no assurance” of a definitive agreement. If one is signed by December 31, 2026, the company anticipates a closing “between late in the second quarter of 2027 and the end of 2027.”
- Real estate is carried at $46,550,000 (June 30, 2026: $53,990,000). Cash is $3,346,118 and loans payable are $10,634,946. The Cortlandt Manor loan was extended in October 2026 to October 10, 2031 at 7.28%, up from 3.75%.
- There is still no date for a payout. The 10-Q describes the State sale as providing working capital for “a yet to be determined distribution,” and warns that without a Flowerfield closing by the end of 2027 the company “will need additional capital” to fund 2028.
- Two items outside the headline: one of the three largest tenants, about 10% of nine-month rental income, is in default and is booked on a cash basis, and the Chief Operating Officer left on October 2, 2026 with $100,000 of severance.
- Each figure above is a company estimate on the liquidation basis, unaudited, and “should not be taken as an indication of the timing or amount of future distributions.”
CSV · 108 rows
Gyrodyne, LLC Q3 2026 10-Q: net assets per share, the bridge from June 30, the State offer, B2K, debt and timeline
108 rows from Gyrodyne's 10-Q filings for June 30 and September 30, 2026 and its October 20, 2026 8-K, one SEC accession number on every row.
What changed between June 30 and September 30, 2026
Our earlier page on Gyrodyne's net assets and share price walks through every quarter back to 2023. This page is the reading of the quarter that just closed. The balance sheet moved like this.
| Line | June 30, 2026 | September 30, 2026 | Change |
|---|---|---|---|
| Net assets in liquidation | $27,055,247 | $23,640,139 | Down $3,415,108 (our arithmetic) |
| Net assets per share | $12.30 | $10.75 | Down $1.55 |
| Shares used | 2,199,308 | 2,199,308 | No change |
| Real estate held for sale | $53,990,000 | $46,550,000 | Down $7,440,000 |
| Cash and cash equivalents | $3,771,333 | $3,346,118 | Down $425,215 (our arithmetic) |
| Total assets | $57,920,143 | $50,069,518 | Down $7,850,625 (our arithmetic) |
| Loans payable | $10,712,950 | $10,634,946 | Down $78,004 (our arithmetic) |
| Estimated liquidation and operating costs net of estimated receipts | $15,317,135 | $10,843,149 | Down $4,473,986 (our arithmetic) |
| Total liabilities | $30,864,896 | $26,429,379 | Down $4,435,517 (our arithmetic) |
| Estimated selling costs on real estate | $3.00 million | $3.88 million | Up $0.88 million (our arithmetic) |
| B2K closing credit counted in costs | $4.02 million | None | Removed |
| Land entitlement costs still to spend | $1.00 million | $0.82 million | Down $0.18 million (our arithmetic) |
The two quarters tell opposite stories. In the six months to June 30, 2026 the only change in net assets was a $1,196,250 gain from remeasurement. In the nine months to September 30, 2026 the statement of changes shows a $7,440,000 fall in the liquidation value of real estate and a $5,221,142 remeasurement gain, for a net decrease of $2,218,858 from the December 31, 2025 figure.
Where the $3.4 million went
The company's MD&A walks from cash to net assets in millions of dollars at each date. Subtracting the June 30 walk from the September 30 walk gives the quarter's moves (our arithmetic, in millions of dollars, rounded as the filing rounds):
| Item | June 30, 2026 | September 30, 2026 | Effect on net assets |
|---|---|---|---|
| Gross real estate proceeds | 53.99 | 46.55 | -7.44 |
| B2K closing credit | -4.02 | 0 | +4.02 |
| Selling costs on real estate | -3.00 | -3.88 | -0.88 |
| General and administrative expenses | -4.38 | -3.97 | +0.41 |
| Retention bonus plan | -2.23 | -1.93 | +0.30 |
| Free cash flow from rental operations | 1.97 | 2.17 | +0.20 |
| Land entitlement costs | -1.00 | -0.82 | +0.18 |
| Final liquidation and dissolution costs | -1.48 | -1.38 | +0.10 |
| Cash on hand | 3.77 | 3.35 | -0.42 |
| Principal payments on loans | -10.71 | -10.63 | +0.08 |
| Other | -5.85 | -5.82 | +0.03 |
| Net assets | 27.06 | 23.64 | -3.42 |
The first two lines are the whole story. The $7.44 million cut is the gap between the $28.74 million the company had used as the gross value of the B2K contract and the $21.3 million State offer. The filing explains the other side: with B2K being terminated, “the Company no longer expects the transaction with B2K to close,” and the closing credit for the sewage treatment plant and on-site infrastructure, $4,020,222 under the contract, “is no longer included” in estimated costs. The MD&A also names savings of about $308,000 in retention bonuses, $1,233,000 from timing of sales and the employee restructuring, and about $70,000 on a Cortlandt Manor prepayment penalty, against about $900,000 of higher selling costs that include estimated fees for terminating B2K. Those two lines net to about $3.42 million (our arithmetic), nearly the whole quarterly decline.
Per share, the same pieces are about $3.38 for the $7.44 million cut and about $1.83 for the $4.02 million credit, against 2,199,308 shares (our arithmetic).
The State offer against the B2K contract
| B2K Smithtown LLC contract | New York State (NYSDEC) offer | |
|---|---|---|
| Status in the 10-Q | Signed July 30, 2025; the company “no longer expects the transaction with B2K to close” | Non-binding offer; no definitive agreement |
| Price | $24,000,000 to $28,740,000 | $21.3 million |
| Land | About 49 acres of undeveloped Flowerfield | The undeveloped portion of Flowerfield |
| Conditions | Subdivision and site plan approval, then the buyer's own approvals | A definitive agreement and the State's acquisition process, including State, county and town approvals |
| Sewage plant and infrastructure | Closing credit of $4,020,222 | Offer would permit subdivision without investment by the company in a sewage treatment plant or infrastructure |
| Latest possible closing | Could extend to October 2029, or February 2030 if both extensions are used | Late in the second quarter of 2027 to the end of 2027, if a definitive agreement is signed by December 31, 2026 |
| What happens to the other deal | Termination agreed in principle; payable only from State sale proceeds | The B2K termination is contingent on the State sale closing |
Three points in the text matter to a holder. First, the termination with B2K is not final: the 10-Q says the agreement in principle “is not binding” and that there is no assurance B2K “will not seek to enforce its rights.” Second, the termination payment is not stated: it is “included in estimated selling costs,” but the 10-Q gives no figure for it. Third, because the termination is payable from State sale proceeds, if the State sale does not close, the cost is not triggered, but neither is the $21.3 million received (our reading of the 10-Q's sequence).
On the court case, the 10-Q says the company “does not currently expect the Article 78 Proceeding to have a material effect on the closing of a sale of the undeveloped portion of Flowerfield to New York State.” The Supreme Court of the State of New York dismissed the Article 78 petition in its entirety on October 11, 2024. The petitioners appealed, and the 10-Q's latest dated step is the Town's July 28, 2025 reply to that appeal. The company still assumes the developed part of Flowerfield will not sell until the case ends.
When could money come back: what the 10-Q says and does not say
The 10-Q does not give a distribution date. It says the Board decides the “nature, amount and timing” of all distributions in its sole discretion. It links cash to the State closing: closing the sale “would provide adequate additional working capital to fund a yet to be determined distribution to our shareholders.” It then states the other side: “Absent closing on the sale of the Flowerfield property by the end of 2027, Management believes the Company will need additional capital to properly fund operations through the end of 2028.”
The timeline in the filing, in order:
| Step | What the 10-Q says | Date it gives |
|---|---|---|
| Definitive agreement with the State | Must be signed for the closing window to apply | By December 31, 2026 |
| State closing | Subject to the State's acquisition process and approvals | Late in the second quarter of 2027 to the end of 2027 |
| Flowerfield subdivision approval | Expected shortly after a State closing | After the State closing |
| Cortlandt Manor subdivision approval | If a subdivision is pursued by the future buyer | Mid-2027 |
| Cortlandt Manor sale | Company aims to close | No later than the end of 2028 |
| Liquidation complete (assumption in the estimate) | Unchanged assumption | December 31, 2028 |
Two other lines in the filing limit what a payout could be. Shareholders “could be held liable for payments made to them and could be required to return all or a part of the distributions” if creditors' claims exceed what is left. And the company says it is required to provide for known and unknown liabilities, which “could substantially delay or limit its ability to make future distributions.” A 2015 class action settlement also restricts sales to prices at or above the 2014 appraised values; the 10-Q says that after the $7,440,000 cut, assuming the State sale at $21.3 million, the aggregate estimated value of the properties not yet sold “exceeded the respective 2014 aggregate appraised value.”
Debt, cash and who is paid first
| Item | Amount | Terms in the 10-Q |
|---|---|---|
| Cash and cash equivalents, September 30, 2026 | $3,346,118 | The MD&A rounds it to about $3.35 million |
| 2018 bank line | $1,762,123 | 3.85% fixed; matures April 30, 2028 |
| 2019 bank line | $2,413,182 | 3.85% fixed; matures May 20, 2028; both lines secured by about 31.8 acres of the industrial park |
| Cortlandt Manor mortgage, September 30, 2026 | $4,481,812 | 3.75% to October 10, 2026 |
| Cortlandt Manor mortgage after the October 2026 extension | $4,041,482 | Extended to October 10, 2031; rate reset to 7.28%; paydown of $431,411 |
| Debt due in the year ending September 30, 2027 | $688,787 | From the maturity schedule |
| Debt due in the year ending September 30, 2028 | $5,976,462 | From the maturity schedule |
| Total debt payable | $10,634,946 | The balance sheet's loans payable |
| Deferred vendor fees (accounts payable) | $1,503,822 | Informal, unwritten deferrals; $1,354,598 at December 31, 2025 |
| Directors' deferred compensation (accrued) | $2,185,501 | $2,047,797 at December 31, 2025 |
The company says vendors have informally agreed to defer 50% of their fees until the first subdivided lot is sold, but that the timeline to the end of 2028 “is resulting in economic pressure” for a partial payment. The loans payable also include a $1,500,000 term mortgage loan with LLYR Resources, LLC, which the company extended for 24 months from January 1, 2026 at a revised rate of 15%, and a $477,829 balance converted from a vendor's unpaid invoices; the five loans add up to the $10,634,946 total (our arithmetic).
Tenants and staff
One of the three largest tenants, about 10% of rental income for the nine months, was in default at September 30, 2026. The company records its rent on a cash basis and says it is working to cure the default; about $456,000 of that tenant's rent is inside the estimated costs net of receipts. The three largest tenants were 29%, 18% and 10% of nine-month rental income. In the nine months the company signed three new leases and six renewals, about 13,500 square feet and about $230,000 of annual revenue, and had three terminations of about 6,300 square feet. The Chief Operating Officer's employment ended on October 2, 2026, and the 10-Q says the $100,000 severance was paid on October 22, 2026.
The price: what we can and cannot say
The 10-Q reports net assets, not a market price, and no Nasdaq quote for the shares appears in it. We did not save a dated quote, so we do not set the $10.75 beside a price. To compare them, take the GYRO closing price on Nasdaq for a stated date and set it beside the per-share figure for the nearest balance-sheet date, writing down both dates. Our earlier page explains why the figure is a company estimate after accrued costs through 2028, not a payout, and why per-share figures before March 2024 are not like-for-like.
What a reader can do with this
This is analysis of public documents, not investment, legal or tax advice. None of these figures is a distribution date. What the filings let a holder check:
- Watch for the definitive State agreement. The closing window in the 10-Q applies only if it is signed by December 31, 2026.
- Read any B2K termination in full when it is signed. The payment amount is not in the 10-Q and is paid out of State proceeds.
- Use $10.75 as an estimate with a range, not a payout. The company says it could change with “the timing of the sales, terms for the sale to the State and estimated termination fees.”
- Keep your own cost basis per lot if you hold shares bought at different times. The share count changed in 2024, and any liquidating distribution will need a basis for each lot.
- Compare with other liquidations we cover if you want a sense of how payouts are handled: Elme Communities, Aimco and Steele Creek Capital.
- Check the Nasdaq price with its date if you are thinking about selling, and compare it with $10.75 as of the same period.
FAQ
All figures are from SEC filings read on EDGAR on November 17, 2026. Gyrodyne, LLC (CIK 1589061): Form 10-Q for the quarter ended September 30, 2026, filed November 13, 2026 (accession 0001437749-26-036653); Form 10-Q for the quarter ended June 30, 2026, filed August 13, 2026 (0001437749-26-027458); and Form 8-K filed October 20, 2026 (0001437749-26-033007). This is analysis of public documents, not investment, legal or tax advice.